An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
Ole Audun Werner Haabeth, Julian J.K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra K. Czerwinski, Blaine G. McCarthy, Abigail E. Powell, Paul A. Wender, Robert M. Waymouth, Ronald Levy
Abstract
T cell memory.
Topics & Concepts
ImmunogenicityVaccinationVirologyMessenger RNAAntibodyNeutralizing antibodyBiologyImmunologyMedicineGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene DeliveryImmunotherapy and Immune Responses